Upgrade to SI Premium - Free Trial

Medline Inc (MDLN) PT Lowered to $45 at Baird

June 3, 2026 6:16 AM
Baird analyst Eric Coldwell lowered the price target on Medline Inc (NASDAQ: MDLN) to $45.00 (from $57.00) while maintaining a Outperform rating.

Categories

Analyst PT Change